IRCT20170722035222N2 IRCT 2018-04-18 Esfahan University of Medical Sciences evaluation of Curcuma tablet efficacy in nonalcoholic fatty liver patients Evaluation of curcuma (turmeric) efficacy on biochemical and liver sonography criteria in non-alcoholic fatty liver patients 2017-09-23 anticipated 100 Complete https://irct.ir/trial/26677 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: the results in both groups compare and analyse with SPSS sofware. using Paired T test, independent T test and X2 for intra group and inter groups comparing, Randomization description: A total of 100 patients were randomly selected from NAFLD. Then, patients were randomly assigned to two equal groups of 50 patients with curcumin and control. The curcumin group received a single dose of 20 mg of curcuma per day for 8 weeks and the control group received the same amount of placebo for eight weeks, Blinding description: In this study, after signing up the testimonial, as a research-therapeutic drug, Curcuma was given to the first group and placebo given to the second group. Patients are not informed about whether they are taking placebo or Curcuma. N/A nonalcoholic fatty liver. Intervention 1: Intervention group: Patients in this group are treated with one 20 mg Curcuma tablet (Dina Company) for 8 weeks. Intervention 2: Control group: Patients in the control group receive one placebo tablet per day for 8 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is there is no more information available.